Mirae Asset Global Investments’s Acrivon Therapeutics ACRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.44K Buy
2025
Q1
$2.33K Buy
2024
Q4
$6.14K Buy